In culture, LTB4, via BLT2, promotes EMT and the expression of vimentin in some human cancer cell lines through activation of reactive oxygen species, NF-κB, TGF-β, and ERK (Kim et al., 2014). The gene discussed is NFKB1; the disease is cancer.